Safety of medicines

With the increasing risk of falsified medicines both in Lithuania and around the world, the Falsified Medicines Directive (Directive 2011/62/EU of the European Parliament and of the Council) was adopted, which provides for measures to prevent illegal medicines from entering our markets.

The Directive provides for the introduction of measures to verify the authenticity of medicinal products and to improve the quality of their ingredients throughout Europe. These implemented measures will facilitate the identification of falsified medicines, ensure greater control, and contribute to the overall protection of public health in the EU.

In Lithuania, the National Medicines Verification Organization (NMVO) is responsible for the implementation of the Falsified Medicines Directive. Its main objective is to create and administer a national data repository designed to verify the authenticity of or deactivate the unique identifiers of prescription medicines provided in Lithuania.

The implementation of the Falsified Medicines Directive in EU countries is ensured by the European Medicines Verification Organisation (EMVO), established in early 2015 and bringing together all the stakeholders involved in the implementation of the Falsified Medicines Directive and ensuring the development of a common system of protection against the entry of illegal medicines into the legal supply chain.

For more information: European Medicines Verification Organisation (EMVO) and National Medicines Verification Organization (NMVO)